Your browser doesn't support javascript.
loading
Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial.
Chen, Xiaofeng; Xu, Xiang; Wang, Danping; Liu, Jinyuan; Sun, Jing; Lu, Mingjie; Wang, Rui; Hui, Bingqing; Li, Xiaofei; Zhou, Chenchen; Wang, Min; Qiu, Tianzhu; Cui, Shiyun; Sun, Nana; Li, Yang; Wang, Fufeng; Liu, Cuicui; Shao, Yang; Luo, Jinhua; Gu, Yanhong.
Afiliação
  • Chen X; Department of Oncology and Cancer Rehabilitation Center, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.
  • Xu X; Department of Oncology, Pukou Branch of Jiangsu People's Hospital, Nanjing, China.
  • Wang D; Department of Thoracic Surgery, Taixing People's Hospital, Taixing, Jiangsu, China.
  • Liu J; First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Sun J; Department of Oncology, Nantong First People's Hospital, The Second Affiliated Hospital of Nantong University, Nantong, China.
  • Lu M; Department of Thoracic Surgery, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.
  • Wang R; Department of Oncology and Cancer Rehabilitation Center, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.
  • Hui B; Department of Oncology and Cancer Rehabilitation Center, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.
  • Li X; First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Zhou C; First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Wang M; First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Qiu T; First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, China.
  • Cui S; Department of Digestive Endoscopy, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.
  • Sun N; Department of Oncology and Cancer Rehabilitation Center, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.
  • Li Y; Department of Oncology and Cancer Rehabilitation Center, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.
  • Wang F; Department of Radiology, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.
  • Liu C; Department of Pathology, Jiangsu Province People's Hospital and Nanjing Medical University First Affiliated Hospital, Nanjing, Jiangsu, China.
  • Shao Y; Nanjing Geneseeq Technology Inc, Nanjing, Jiangsu, China.
  • Luo J; Nanjing Geneseeq Technology Inc, Nanjing, Jiangsu, China.
  • Gu Y; Nanjing Geneseeq Technology Inc, Nanjing, Jiangsu, China.
J Immunother Cancer ; 11(2)2023 02.
Article em En | MEDLINE | ID: mdl-36759013
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Limite: Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China